More on NTLA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (6.3 Score)
- Holders

Upcoming Events

- Earnings (7/31/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Intellia Therapeutics (NQ:NTLA)
Delayed: 13.44 +0.29 (2.21%)
Prev. Close $13.15  
Open$12.73 
52 Wk High$30.40 
52 Wk Low$11.86 
Day High$13.54 
Day Low$12.55 
P/E N/A  
EPS$0.00 
Volume3,322,786 

Friends, Peers and Foes (?): CRSP, BEAM, EDIT, ALNY, BHVN (more...)

Mar 6, 2026 04:01 PM Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 4, 2026 05:56 AM Jones Trading Upgrades Intellia Therapeutics (NTLA) to Buy
Mar 3, 2026 04:24 PM Form 4 Intellia Therapeutics, For: Mar 01 Filed by: BASTA JAMES
Mar 3, 2026 04:24 PM Form 4 Intellia Therapeutics, For: Mar 01 Filed by: LEONARD JOHN M
Mar 3, 2026 04:21 PM Form 4 Intellia Therapeutics, For: Mar 01 Filed by: Dube Michael P
Mar 3, 2026 04:21 PM Form 4 Intellia Therapeutics, For: Mar 01 Filed by: Schultes Birgit C
Mar 3, 2026 04:21 PM Form 4 Intellia Therapeutics, For: Mar 01 Filed by: Dulac Edward J III
Mar 3, 2026 04:21 PM Form 4 Intellia Therapeutics, For: Mar 01 Filed by: Lebwohl David
Mar 3, 2026 04:21 PM Form 4 Intellia Therapeutics, For: Mar 01 Filed by: Clark Eliana
Mar 3, 2026 09:54 AM Brookline Capital Markets Reiterates Buy Rating on Intellia Therapeutics (NTLA), PT $106
View All Articles

Entities mentioned with NTLA

View All Entities